Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.51 Million USD | 47.71% |
| 2022 | 3.02 Million USD | 2.34% |
| 2021 | 2.95 Million USD | -15.03% |
| 2020 | 3.47 Million USD | 43.35% |
| 2019 | 2.42 Million CAD | 300.7% |
| 2018 | 604.81 Thousand CAD | -59.38% |
| 2017 | 1.48 Million CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.43 Million USD | 13.32% |
| 2024 Q1 | 1.26 Million USD | 19.83% |
| 2023 Q1 | 1.21 Million USD | 116.99% |
| 2023 FY | 4.46 Million USD | 47.71% |
| 2023 Q4 | 1.08 Million USD | 2.67% |
| 2023 Q3 | 1.06 Million USD | 0.95% |
| 2023 Q2 | 1.05 Million USD | -13.44% |
| 2022 Q1 | 436 Thousand USD | -12.27% |
| 2022 Q3 | 1.09 Million USD | 16.45% |
| 2022 Q4 | 559 Thousand USD | -48.72% |
| 2022 Q2 | 936 Thousand USD | 114.68% |
| 2022 FY | 3.02 Million USD | 2.34% |
| 2021 FY | 2.95 Million USD | -15.03% |
| 2021 Q1 | 252 Thousand USD | -77.77% |
| 2021 Q3 | 987 Thousand USD | -18.83% |
| 2021 Q4 | 497 Thousand USD | -49.65% |
| 2021 Q2 | 1.21 Million USD | 382.54% |
| 2020 Q1 | 419.27 Thousand CAD | -66.33% |
| 2020 Q3 | 1.46 Million CAD | 247.67% |
| 2020 Q4 | 1.13 Million USD | -22.65% |
| 2020 FY | 3.47 Million USD | 43.35% |
| 2020 Q2 | 421.6 Thousand CAD | 0.56% |
| 2019 Q1 | 705.83 Thousand CAD | 87.6% |
| 2019 Q4 | 1.24 Million CAD | 473.96% |
| 2019 Q3 | 216.96 Thousand CAD | -13.7% |
| 2019 Q2 | 251.4 Thousand CAD | -64.38% |
| 2019 FY | 2.42 Million CAD | 300.7% |
| 2018 Q3 | 48.74 Thousand CAD | -26.38% |
| 2018 Q1 | 112.48 Thousand CAD | -82.59% |
| 2018 FY | 604.81 Thousand CAD | -59.38% |
| 2018 Q4 | 376.24 Thousand CAD | 671.87% |
| 2018 Q2 | 66.21 Thousand CAD | -41.13% |
| 2017 Q3 | 225.49 Thousand CAD | -39.63% |
| 2017 FY | 1.48 Million CAD | 0.0% |
| 2017 Q4 | 645.9 Thousand CAD | 186.44% |
| 2017 Q2 | 373.51 Thousand CAD | 77.71% |
| 2017 Q1 | 210.18 Thousand CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -77.02% |
| BrainsWay Ltd. | 23.09 Million USD | 80.451% |
| Cerus Corporation | 86.4 Million USD | 94.775% |
| Envoy Medical, Inc. | -473 Thousand USD | 1054.338% |
| electroCore, Inc. | 13.22 Million USD | 65.87% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -7300.034% |
| IceCure Medical Ltd | 1.3 Million USD | -247.232% |
| Inogen, Inc. | 126.69 Million USD | 96.437% |
| OrthoPediatrics Corp. | 111.25 Million USD | 95.943% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 174.612% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 9636.127% |
| MaxCyte, Inc. | 36.54 Million USD | 87.648% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -888.796% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -5206.867% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.072% |
| PAVmed Inc | -3.96 Million USD | 213.761% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 182.298% |
| RxSight, Inc. | 53.76 Million USD | 91.604% |
| Sight Sciences, Inc. | 69.17 Million USD | 93.474% |
| SI-BONE, Inc. | 109.42 Million USD | 95.875% |
| TELA Bio, Inc. | 40.11 Million USD | 88.746% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 97.029% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 45.424% |
| Acutus Medical, Inc. | -3.13 Million USD | 243.896% |
| Talis Biomedical Corporation | 371 Thousand USD | -1116.717% |
| Spectral AI, Inc. | 7.88 Million USD | 42.715% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 168.477% |
| CVRx, Inc. | 33.03 Million USD | 86.337% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -510.394% |
| Bioventus Inc. | 328.19 Million USD | 98.625% |
| Venus Concept Inc. | 52.16 Million USD | 91.347% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 71.621% |
| LivaNova PLC | 771.25 Million USD | 99.415% |
| 908 Devices Inc. | 25.32 Million USD | 82.174% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 98.545% |
| Nemaura Medical Inc. | -1.47 Million USD | 405.747% |
| NeuroPace, Inc. | 48.12 Million USD | 90.62% |
| LENSAR, Inc. | 21.1 Million USD | 78.614% |
| Apyx Medical Corporation | 14.12 Million USD | 68.036% |
| Cutera, Inc. | 41.49 Million USD | 89.121% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 75.548% |
| BioSig Technologies, Inc. | 18 Thousand USD | -24977.894% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 95.621% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 66.843% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.492% |
| Axonics, Inc. | 274.55 Million USD | 98.356% |
| Outset Medical, Inc. | 29 Million USD | 84.434% |
| IRIDEX Corporation | 21.8 Million USD | 79.3% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 93.647% |
| IRadimed Corporation | 50.15 Million USD | 91.0% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -1472.83% |
| INVO Bioscience, Inc. | 1.08 Million USD | -315.603% |
| Telesis Bio, Inc. | 16.95 Million USD | 73.369% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 95.998% |
| Varex Imaging Corporation | 256.9 Million USD | 98.243% |
| Quipt Home Medical Corp. | 163.84 Million USD | 97.245% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1211.828% |
| Pulmonx Corporation | 50.75 Million USD | 91.106% |
| Dynatronics Corporation | 7.63 Million USD | 40.877% |
| Modular Medical, Inc. | -768 Thousand USD | 687.763% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 18.637% |
| Semler Scientific, Inc. | 61.2 Million USD | 92.624% |
| InMode Ltd. | 411.34 Million USD | 98.903% |
| Bruker Corporation | 1.51 Billion USD | 99.702% |
| Cytosorbents Corporation | 22.39 Million USD | 79.841% |
| DexCom, Inc. | 2.28 Billion USD | 99.803% |
| Align Technology, Inc. | 2.71 Billion USD | 99.834% |
| Viveve Medical, Inc. | 620 Thousand USD | -628.068% |
| ZimVie Inc. | 290.38 Million USD | 98.445% |
| Movano Inc. | -158 Thousand USD | 2956.975% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 95.875% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -5206.867% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 98.772% |
| Insulet Corporation | 1.15 Billion USD | 99.611% |
| enVVeno Medical Corporation | -546 Thousand USD | 926.744% |
| Surmodics, Inc. | 93.05 Million USD | 95.149% |
| iCAD, Inc. | 14.53 Million USD | 68.946% |
| Nuwellis, Inc. | 4.98 Million USD | 9.412% |
| Biotricity, Inc. | 8.35 Million USD | 45.981% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 98.64% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 1357.188% |
| InspireMD, Inc. | 1.8 Million USD | -149.807% |
| PAVmed Inc. | -3.96 Million USD | 213.761% |
| BIOLASE, Inc. | 16.72 Million USD | 73.009% |
| Beyond Air, Inc. | -1.3 Million USD | 445.373% |
| FONAR Corporation | 45.14 Million USD | 90.0% |
| AxoGen, Inc. | 127.87 Million USD | 96.47% |
| Vivani Medical, Inc. | -357 Thousand USD | 1364.432% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 97.687% |
| Inari Medical, Inc. | 434.56 Million USD | 98.961% |
| UFP Technologies, Inc. | 112.22 Million USD | 95.978% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -35957.361% |
| Tenon Medical, Inc. | 1.24 Million USD | -263.741% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 5672.865% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -71.826% |
| AdaptHealth Corp. | 479.56 Million USD | 99.059% |
| Sintx Technologies, Inc. | 1.84 Million USD | -144.928% |
| NanoVibronix, Inc. | 1.53 Million USD | -193.69% |
| Quanterix Corporation | 70.64 Million USD | 93.61% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1211.828% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 67.895% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 91.447% |
| TransMedics Group, Inc. | 154.09 Million USD | 97.071% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -1.37% |
| NeuroMetrix, Inc. | 3.94 Million USD | -14.354% |
| Hyperfine, Inc. | 4.75 Million USD | 5.108% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 95.78% |
| Biomerica, Inc. | 611 Thousand USD | -638.792% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 89.172% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 678.013% |
| Silk Road Medical, Inc | 127.08 Million USD | 96.448% |